Paid Clinical Trials Buffalo

Discover 630 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 630

Propranolol with Pembrolizumab & mFOLFOX

Recruiting

PHASE2

Sponsor:

Roswell Park Cancer Institute

Location:

Buffalo NY

Code:

NCT05651594

Conditions

Clinical Stage II Esophageal Adenocarcinoma AJCC v8

Clinical Stage III Esophageal Adenocarcinoma AJCC v8

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IV Esophageal Adenocarcinoma AJCC v8

Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Fluorouracil

Leucovorin

Single vs. Multiple

Recruiting

Sponsor:

Weill Medical College of Cornell University

Location:

Hamilton, Toronto, London, Cleveland OHshow 35 more

Code:

NCT04124120

Conditions

Heart Diseases

Coronary Artery Disease

Coronary Artery Bypass Grafting

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single arterial graft

Multiple arterial grafting

Observational Study

Recruiting

Sponsor:

Inari Medical

Location:

Buffalo NY, Rochester NY, Erie PA, Cleveland OHshow 48 more

Code:

NCT06055920

Conditions

Pulmonary Embolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FlowTriever System

Anticoagulation Agents

Marstacimab

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Hamilton, New Hyde Park NY, Iowa City IA, Edmontonshow 1 more

Code:

NCT05145127

Conditions

Hemophilia A

Hemophilia B

Eligibility Criteria

Sex: Male

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

PF-06741086

IPN10200

Recruiting

PHASE2

Sponsor:

Ipsen

Location:

Williamsville NY, Ann Arbor MI, Baltimore MD, Bronx NYshow 11 more

Code:

NCT06625060

Conditions

Episodic Migraine

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

IPN10200

Placebo

IPN10200 dose A

IPN10200 dose B

Sotatercept

Recruiting

PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Hamilton, Toronto, Rochester NY, Liverpool NYshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

Exercise & Nutrition

Recruiting

Sponsor:

Roswell Park Cancer Institute

Location:

Buffalo NY

Code:

NCT06565260

Conditions

Hematopoietic and Lymphatic System Neoplasm

Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Exercise Intervention

Medical Device Usage and Evaluation

Nutritional Intervention

Physical Performance Testing

Questionnaire Administration

Rezpegaldesleukin

Recruiting

PHASE2

Sponsor:

Nektar Therapeutics

Location:

Oakville, Markham, Richmond Hill, Clinton Township MIshow 11 more

Code:

NCT06340360

Conditions

Alopecia Areata

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Rezpegaldesleukin

Placebo

Pelacarsen

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Buffalo NY, Detroit MI, Easton PA, Flint MIshow 73 more

Code:

NCT06267560

Conditions

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TQJ230

Placebo

Crenolanib vs. Midostaurin

Recruiting

PHASE3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Buffalo NY, Detroit MI, New Brunswick NJ, Hackensack NJshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin